NasdaqCM - Nasdaq Real Time Price USD
Surrozen, Inc. (SRZN)
10.57
+0.69
+(7.03%)
As of 1:27:21 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-17,628
-17,628
-40,363
-44,145
-48,813
Investing Cash Flow
-26
-26
51,723
38,309
-77,708
Financing Cash Flow
16,176
16,176
276
-2,565
124,630
End Cash Position
35,253
35,253
36,731
25,095
33,496
Capital Expenditure
-26
-26
-398
-728
-1,269
Issuance of Capital Stock
16,043
16,043
--
--
124,220
Repurchase of Capital Stock
--
--
-4
-2,607
--
Free Cash Flow
-17,654
-17,654
-40,761
-44,873
-50,082
12/31/2021 - 1/11/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
87S.BE Roivant Sciences Ltd
9.31
+1.82%
23J0.F ProMIS Neurosciences, Inc.
0.5150
-4.63%
4A3.F Immatics N.V.
3.9300
+2.13%
M8W.F MediWound Ltd.
15.60
+0.65%
JSPRW Jasper Therapeutics, Inc.
0.0814
+34.55%
CYTOF Altamira Therapeutics Ltd.
0.0710
+1.43%
DRUG.CN Bright Minds Biosciences Inc.
47.48
0.00%
ANEB Anebulo Pharmaceuticals, Inc.
0.9950
+2.58%
MAZE Maze Therapeutics, Inc.
8.68
-9.16%
PVLA Palvella Therapeutics, Inc.
26.11
-1.69%